Emvision Medical Devices Ltd. · ASX:EMV
Emvision Medical Devices — Bioshares Biotech Summit (July 2019)
19 slides from Emvision Medical Devices's conference presentation, Jul 25, 2019
Slide 1: Medical Imaging Innovation
www.emvision.com.au For personal use only MEDICAL IMAGING INNOVATION
Slide 2: Microwave imaging as an innovative imaging modality
MEDICAL IMAGING INNOVATION For personal use only Microwave imaging is a truly innovative imaging modality that has disruptive implications for diagnostics, monitoring and the delivery of care in the future XRAY ULTRASOUND CT MRI + PET ELECTROMAGNETIC MICROWAVE 1895 1950’s 1960’s 1980’s NON-DESTRUCTI
Slide 3: Stroke & Traumatic Brain Injury
1ST APPLICATION STROKE & For personal use only TRAUMATIC BRAIN INJURY Stroke is the second leading cause of death world wide with 1 in 6 people having a stroke in their lifetime 1 Traumatic Brain Injury (TBI) is the most frequent cause of death and disability worldwide 2 There are effective treatmen
Slide 4: Typical patient journey and timeline
TYPICAL PATIENT JOURNEY AND TIMELINE EMvision’s opportunity is to bring stoke and traumatic brain injury decision support and monitoring to the patient Stroke Onset For personal use only 15 mins to 2.5 hours < 2.5 hours < 3 hours < 24 hours <24 hours - 3 weeks <3 weeks - 3 years+ Pre-Hospital Triage
Slide 5: EMvision's Brain Scanner
EMVISION’S BRAIN SCANNER PORTABLE COST-EFFECTIVE SAFE RAPID The Company aims to develop a clinical device that delivers these features For personal use only CLINICAL HOSPITAL AMBULANCE TRIAL UNIT COMMERCIAL UNIT COMMERCIAL UNIT EMvision is in the late stages of EMvision’s 1st generation commercial D
Slide 6: Technology Overview
TECHNOLOGY OVERVIEW For personal use only Array of antennas send pulses of low-power electromagnetic waves into the head Waves penetrate tissue in a non-ionizing and harmless manner and get scattered based on the electrical properties of tissue Sensors in the helmet detect these interactions to iden
Slide 7: Attractive Revenue Model
ATTRACTIVE REVENUE MODEL For personal use only DEVICE SALES DISTRIBUTION Each sale has multiple Future distribution partners purchase equipment, proposed recurring revenue consumables, accessories and spare parts from streams EMvision and on-sell to their network PURCHASING MODELS CONSUMABLES CAPITA
Slide 8: Key Addressable Markets
KEY ADDRESSABLE MARKETS For personal use only North America 48,000 Ambulances Europe 5,000 Hospitals 60,000 Ambulances China 15,000 Hospitals 30,000 Hospitals SECONDARY MARKETS: Rural / Remote Australia Military Humanitarian 5,200 Ambulances Aged Care Sport 1,300 Hospitals Air / Ships www.emvision.c
Slide 9: Partners & Collaborators
PARTNERS & COLLABORATORS For personal use only Awarded EMvision a $2.6M CRC-P non-dilutive Developer of EMvision’s IP, CRC-P partner, and GE Healthcare is the $19 billion healthcare business cash grant, over three years, in Dec’17. Australia's most successful commercialisation of GE (NYSE:GE) and a
Slide 10: Pilot-Clinical Trial Roadmap
PILOT-CLINICAL TRIAL ROADMAP For personal use only Q1-Q2 Q3 Q4 CY 2019 CY 2019 CY 2019 ISO 13485 Clinical unit bill of materials (BOM) Delivery of clinical Certification review, release and procurement trial units to hospital Successful Healthy Human Trials Commence fabrication and Clinical site ini
Slide 11: Point-of-Care Device Landscape
POINT-OF-CARE DEVICE LANDSCAPE EMvision is setting out to capture a niche with superior ease of use and image reconstruction For personal use only POTENTIAL CLINICAL ADVANTAGES: “The EMTensor Brain Scanner Multi-algorithmic Image Fusion “Strokefinder MD100 is a device could provide rapid screening o
Slide 12: Product Pipeline
For personal use only PRODUCT Device Discovery Preclinical Research & Healthy Ethics Pilot Pivotal Regulatory Clearance & PIPELINE & Concept Prototype Human Trials Clearance Clinical Trial Clinical Trial Commercialisation BRAIN SCANNER Identify and monitor Q4 2019 2020 stroke and traumatic brain inj
Slide 13: Identifying & Monitoring Liver Disease
2nd APPLICATION For personal use only IDENTIFYING & MONITORING LIVER DISEASE Over 1 BILLION people globally have liver disease 1 in 4 people worldwide have a variant known as non-alcoholic fatty liver disease (NAFLD) 1 Approximately 20% of NAFLD cases are classified as non-alcoholic steatohepatitis
Slide 14: Early Detection and Monitoring of Liver Disease
EARLY DETECION AND MONITORING OF LIVER DISEASE For personal use only GLOBAL EPIDEMIC FUELED BY ZERO PRACTICAL DIAGNOSTIC THE BENEFITS OF APPLYING OBESITY RATES AND DIABETES AND MONITORING SOLUTIONS EM MICROWAVE IMAGING The prevalence of NAFLD is constantly Invasive, painful and costly Quantify fat i
Slide 15: EMvision Torso Scanner Development
EMVISION TORSO SCANNER DEVELOPMENT EMvision is exploring the feasibility of a non-invasive and cost-effective Torso For personal use only Scanner to identify the severity and monitor the progression of NAFLD and NASH TISSUE CHARACTERISATION PHANTOM FABRICATED Tissue characterisation work to An enhan
Slide 16: Common Challenges
COMMON CHALLENGES For personal use only Bringing medical devices to market is a complex process; a few critical considerations to look out for are: Ensuring that you have the Selecting the right best application. Don’t try The right regulatory path. clinical outcomes for 01 and get it to do everythi
Slide 17: Team
TEAM Significant experience developing and commercialising medical devices For personal use only Dr Ron Weinberger John Keep Scott Kirkland Prof Stuart Crozier Robert Tiller Chief Executive Officer Executive Chairman Executive Director Clinical Development Advisor Product Design & Former Exec Direct
Slide 18: Get in Touch
www.emvision.com.au For personal use only GET IN TOUCH Dr Ron Weinberger Scott Kirkland CEO, EMvision Executive Director, EMvision E: rweinberger@emvision.com.au E: skirkland@emvision.com.au P: 02 8667 5337 P: 02 8667 5337
Slide 19: Disclaimer
DISCLAIMER For personal use only This presentation has been prepared by EMvision Medical Devices Limited (“EMvision” or “the Company”). This presentation is not a financial product or investment advice or recommendation, offer or invitation by any person or to any person to sell or purchase securiti
EMvision Medical Devices — Bioshares Biotech Summit (July 2019) on 6ix